Risks of Kidney Failure Associated With Consumption of Herbal Products Containing Mu Tong or Fangchi: A Population-Based Case-Control Study
- 31 March 2010
- journal article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 55 (3), 507-518
- https://doi.org/10.1053/j.ajkd.2009.10.055
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acidNephrology, 2009
- Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insuranceNephrology Dialysis Transplantation, 2008
- All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in TaiwanThe Lancet, 2008
- The prescribing of Chinese herbal products in Taiwan: a cross‐sectional analysis of the national health insurance reimbursement databasePharmacoepidemiology and Drug Safety, 2008
- Epidemiological Features of CKD in TaiwanAmerican Journal of Kidney Diseases, 2007
- High Prevalence and Low Awareness of CKD in Taiwan: A Study on the Relationship Between Serum Creatinine and Awareness From a Nationally Representative SurveyAmerican Journal of Kidney Diseases, 2006
- Rapidly Progressive Interstitial Renal Fibrosis Associated with Chinese Herbal MedicationsAmerican Journal of Nephrology, 2001
- Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugsAmerican Journal of Kidney Diseases, 2000
- Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbsThe Lancet, 1993
- Incidence of advanced chronic renal failure and the need for end stage renal replacement treatment.BMJ, 1990